Sanfilippo Syndrome, often likened to early-onset Alzheimer’s and dementia in children, is a devastating genetic disorder. Initially, children with Sanfilippo Syndrome develop normally, but as the disease advances, they experience difficulties in speech, learning, and mobility. Behavioral issues such as hyperactivity, anxiety, and sleep disturbances also manifest. Eventually, affected children lose their ability to communicate and move, with a shortened lifespan, often not reaching their teenage years.
Leni Forrester, a two-year-old with Sanfilippo Syndrome, has captured attention, with her parents, Emily and Gus, urgently seeking funding for research into potential cures. Leni’s diagnosis journey started when routine genetic screening identified a rare gene in Emily’s family, leading to the heartbreaking diagnosis before symptoms appeared.
Children with Sanfilippo Syndrome lack the enzyme sulfamidase, crucial for breaking down complex sugar molecules. The accumulation of these molecules in brain and nerve cells profoundly impacts their development over time.
Leni’s parents recall the journey that unfolded, triggered by genetic screening results, revealing the rare condition. The subtle signs observed in Leni, such as distinctive physical features and early indications like inward-turning feet, eventually led to the diagnosis.
Sanfilippo Syndrome, affecting 1 in 70,000 births, may have a higher prevalence than reported. Early detection is challenging due to misdiagnosis in the initial stages as symptoms overlap with conditions like autism and ADHD.
The Cure Sanfilippo Foundation emphasizes the importance of recognizing signs early, typically observed between ages one and six, to prompt timely intervention. Families are often reassured as early symptoms can be mistaken for normal developmental phases.
Sanfilippo Syndrome comprises four subtypes – Types A, B, C, and D, each linked to specific enzyme deficiencies in the breakdown of heparan sulfate. Type A is most common, with Types B, C, and D varying in prevalence and disease progression rates.
Leni, diagnosed with Type B, awaits potential life-saving treatments currently in clinical trials. Emily and Gus strive to raise funds for experimental therapies to combat the challenges posed by the rarity of the condition.
Leni’s parents are advocating for support to cover pre-clinical costs for a gene replacement trial, crucial for advancing potential cures. Their efforts to raise awareness and funds have gained attention, including a meeting with popstar Jesy Nelson to spotlight their cause.
In a statement, a Department of Health and Social Care spokesperson expressed commitment to improving diagnosis and access to care for rare conditions like Sanfilippo Syndrome, emphasizing efforts to enhance treatment strategies and understanding of the disease.
Support Leni’s treatment by donating to her GoFundMe here, and follow their journey on <a aria-label=""
